Related Experiment Video

Updated: May 13, 2026

Intrafemoral Injection of Human Hematopoietic Stem and Progenitor Cells into Immunocompromised Mice
03:40

Intrafemoral Injection of Human Hematopoietic Stem and Progenitor Cells into Immunocompromised Mice

Published on: December 8, 2023

Stem cell transplantation in primary myelofibrosis of childhood

Bryan Mitton1, Satiro de Oliveira, Sheeja T Pullarkat

  • 1Department of Pediatrics, Division of Hematology-Oncology, Mattel Children's Hospital at UCLA, Los Angeles, CA, USA.

Journal of Pediatric Hematology/Oncology
|March 21, 2013
PubMed

Insights

Hematopoietic stem cell transplantation offers a cure for pediatric primary myelofibrosis. This report details a successful bone marrow transplant in an infant, leading to complete disease resolution.

Area of Science:

  • Pediatric Hematology
  • Oncology
  • Stem Cell Transplantation

Background:

  • Primary myelofibrosis is a rare myeloproliferative neoplasm.
  • Fewer than 40 pediatric cases are documented globally.
  • Hematopoietic stem cell transplantation (HSCT) is the sole curative option.

Observation:

  • A 6-month-old female infant was diagnosed with primary myelofibrosis.
  • The infant presented with symptoms characteristic of the disease.

Findings:

  • The patient underwent a successful matched unrelated bone marrow transplantation.
  • Complete resolution of primary myelofibrosis was achieved post-transplant.
  • The case highlights the efficacy of HSCT in pediatric patients.

Implications:

  • This case reinforces HSCT as a viable curative therapy for pediatric primary myelofibrosis.
  • Further research into unique pediatric disease characteristics is warranted.
  • Improved understanding can enhance treatment strategies and outcomes for children.

More Related Videos

Use of Hematopoietic Stem Cell Transplantation to Assess the Origin of Myelodysplastic Syndrome06:39

Use of Hematopoietic Stem Cell Transplantation to Assess the Origin of Myelodysplastic Syndrome

Published on: October 3, 2018

Flow Cytometry to Estimate Leukemia Stem Cells in Primary Acute Myeloid Leukemia and in Patient-derived-xenografts, at Diagnosis and Follow Up09:01

Flow Cytometry to Estimate Leukemia Stem Cells in Primary Acute Myeloid Leukemia and in Patient-derived-xenografts, at Diagnosis and Follow Up

Published on: March 26, 2018

Related Concept Videos

Bone Marrow Sampling and Transplants01:22

Bone Marrow Sampling and Transplants

Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy the...
Stem Cell Therapy for Tissue Regeneration01:21

Stem Cell Therapy for Tissue Regeneration

Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell types that...
Differentiation of Common Myeloid Progenitor Cells01:15

Differentiation of Common Myeloid Progenitor Cells

Common myeloid progenitors (CMPs) are oligopotent cells that can differentiate into granulocytes and macrophages. Granulocytes and macrophages are essential for protecting the body against bacterial, viral, or fungal infections. They migrate from the bone marrow into the circulating blood to reach specific tissue sites where they differentiate and help in immune surveillance. However, they survive only for a few days and must be continuously made available to the organism to maintain a robust...